<table id="table9" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9: Effect of Other Agents on the Pharmacokinetics of Raltegravir in Adults</caption>
<col align="left" span="1" valign="top" width="17%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="22%"></col>
<col align="center" span="1" valign="top" width="8%"></col>
<col align="center" span="1" valign="top" width="11%"></col>
<col align="center" span="1" valign="top" width="11%"></col>
<col align="center" span="1" valign="top" width="11%"></col>
<tbody>
<tr>
<th colspan="1">Coadministered Drug</th>
<th colspan="1">Coadministered Drug Dose/Schedule</th>
<th colspan="1">Raltegravir<br/>Dose/Schedule</th>
<th colspan="4">Ratio (90% Confidence Interval) of Raltegravir Pharmacokinetic Parameters with/without Coadministered Drug;<br/>No Effect = 1.00</th>
</tr>
<tr>
<th colspan="1">n</th>
<th colspan="1">C<sub>max</sub>
</th>
<th colspan="1">AUC</th>
<th colspan="1">C<sub>min</sub>
</th>
</tr>
<tr>
<td>atazanavir</td>
<td>400 mg daily</td>
<td>100 mg single dose</td>
<td>10</td>
<td>1.53 <br/>(1.11, 2.12)</td>
<td>1.72 <br/>(1.47, 2.02)</td>
<td>1.95 <br/>(1.30, 2.92)</td>
</tr>
<tr>
<td>atazanavir/ritonavir</td>
<td>300 mg/100 mg daily</td>
<td>400 mg twice daily</td>
<td>10</td>
<td>1.24 <br/>(0.87, 1.77)</td>
<td>1.41 <br/>(1.12, 1.78)</td>
<td>1.77 <br/>(1.39, 2.25)</td>
</tr>
<tr>
<td>efavirenz</td>
<td>600 mg daily</td>
<td>400 mg single dose</td>
<td>9</td>
<td>0.64<br/> (0.41, 0.98)</td>
<td>0.64 <br/>(0.52, 0.80)</td>
<td>0.79 <br/>(0.49, 1.28)</td>
</tr>
<tr>
<td>etravirine</td>
<td>200 mg twice daily</td>
<td>400 mg twice daily</td>
<td>19</td>
<td>0.89 <br/>(0.68, 1.15)</td>
<td>0.90 <br/>(0.68, 1.18)</td>
<td>0.66 <br/>(0.34, 1.26)</td>
</tr>
<tr>
<td>omeprazole</td>
<td>20 mg daily</td>
<td>400 mg single dose</td>
<td>14<br/>(10 for AUC)</td>
<td>4.15<br/>(2.82, 6.10)</td>
<td>3.12<br/>(2.13, 4.56)</td>
<td>1.46<br/>(1.10, 1.93)</td>
</tr>
<tr>
<td>rifampin</td>
<td>600 mg daily</td>
<td>400 mg single dose</td>
<td>9</td>
<td>0.62 <br/>(0.37, 1.04)</td>
<td>0.60 <br/>(0.39, 0.91)</td>
<td>0.39 <br/>(0.30, 0.51)</td>
</tr>
<tr>
<td>rifampin</td>
<td>600 mg daily</td>
<td>400 mg twice daily when administered alone; 800 mg twice daily when administered with rifampin</td>
<td>14</td>
<td>1.62 <br/>(1.12, 2.33)</td>
<td>1.27 <br/>(0.94, 1.71)</td>
<td>0.47 <br/>(0.36, 0.61)</td>
</tr>
<tr>
<td>ritonavir</td>
<td>100 mg twice daily</td>
<td>400 mg single dose</td>
<td>10</td>
<td>0.76<br/> (0.55, 1.04)</td>
<td>0.84 <br/>(0.70, 1.01)</td>
<td>0.99 <br/>(0.70, 1.40)</td>
</tr>
<tr>
<td>tenofovir</td>
<td>300 mg daily</td>
<td>400 mg twice daily</td>
<td>9</td>
<td>1.64 <br/>(1.16, 2.32)</td>
<td>1.49 <br/>(1.15, 1.94)</td>
<td>1.03 <br/>(0.73, 1.45)</td>
</tr>
<tr>
<td>tipranavir/ritonavir</td>
<td>500 mg/200 mg twice daily</td>
<td>400 mg twice daily</td>
<td>15<br/>(14 for C<sub>min</sub>)</td>
<td>0.82 <br/>(0.46, 1.46)</td>
<td>0.76 <br/>(0.49, 1.19)</td>
<td>0.45 <br/>(0.31, 0.66)</td>
</tr>
</tbody>
</table>